Clinical Trials Browser

Pdgfra-Associated Chronic Eosinophilic Leukemia, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Thrombocytosis, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Pyloric Stenosis, Hypertrophic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT04283526 2021-03-04

Study of Select Combinations in Adults With Myelofibrosis

Phase 1 Withdrawn

Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT00718159 2019-01-10

Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia

Phase 1 Completed

23 enrolled 14 charts

Other hematologic neoplasm

Leukemia, Myeloid, Recurrence, Thrombocythemia, Essential, Leukemia, Myeloid, Acute

NCT01134120 2018-04-17

A Study in Myeloproliferative Disorders

Phase 1 Completed

80 enrolled

Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT01520220 2017-04-12

Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms

Phase 1 Completed

100 enrolled

Myeloid

Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT00522574 2011-04-05

A Safety Study of XL019 in Adults With Myelofibrosis

Phase 1 Terminated

100 enrolled

Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

Clinical Trials

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

LIMBER

A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms

A Study of GLB-001 in Patients With Myeloid Malignancies

A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasm

A Study of TAS1553 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia (AML) and Other Myeloid Neoplasms

Study of Select Combinations in Adults With Myelofibrosis

Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia

A Study in Myeloproliferative Disorders

Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms

A Safety Study of XL019 in Adults With Myelofibrosis